| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Barinthus Biotherapeutics Plc. (BRNS) has 0 insiders with recent SEC Form 4 filings, including 4 buys and 0 sells. BRNS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 4, 2021 | Scheeren Joseph | Director | Buy | 3,000 | $17.00 | $51,000.00 | New | +14.1% | -62.1% | |
| May 4, 2021 | Wright Robin | Director | Buy | 14,000 | $17.00 | $238,000.00 | +133.3% | +14.1% | -62.1% | |
| May 4, 2021 | Dawes Karen A63 | Director | Buy | 1,700 | $17.00 | $28,900.00 | New | +14.1% | -62.1% | |
| Apr 30, 2021 | M&g Investment Management Ltd73 | 10% Owner | Buy | 125,000 | $14.40 | $1,800,000.00 | +13.0% | +4.8% | -61.9% |